{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:57:10Z","timestamp":1792173430061,"version":"4.4.0"},"reference-count":444,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":533,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.bbadis.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T13:23:33Z","timestamp":1318857813000},"page":"261-285","source":"Crossref","is-referenced-by-count":627,"title":["\u03b1-Synuclein misfolding and Parkinson's disease"],"prefix":"10.1016","volume":"1822","author":[{"given":"Leonid","family":"Breydo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.10.002_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0888-7543(95)80237-G","article-title":"The human NACP\/alpha-synuclein gene: chromosome assignment to 4q21.3\u2013q22 and TaqI RFLP analysis","volume":"26","author":"Chen","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0010","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0015","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0035","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/brain\/awh081","article-title":"Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication","volume":"127","author":"Singleton","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0040","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0050","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0055","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0065","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1074\/jbc.M504860200","article-title":"Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans","volume":"281","author":"Kuwahara","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0070","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5157-04.2005","article-title":"Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans","volume":"25","author":"Cao","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.0711018105","article-title":"Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model","volume":"105","author":"Hamamichi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/cdd.2009.203","article-title":"Yeast unfolds the road map toward alpha-synuclein-induced cell death","volume":"17","author":"Franssens","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0085","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0090","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb07468.x","article-title":"Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses","volume":"991","author":"Trojanowski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1515\/CCLM.2001.047","article-title":"Parkinson's disease and other alpha-synucleinopathies","volume":"39","author":"Goedert","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0028-3908(03)00140-0","article-title":"Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease","volume":"45","author":"Dev","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0115","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of alpha-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0125","doi-asserted-by":"crossref","first-page":"24065","DOI":"10.1074\/jbc.M002413200","article-title":"Wild-type but not Parkinson's disease-related ala-53\u2192Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli","volume":"275","author":"da Costa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0130","doi-asserted-by":"crossref","first-page":"19573","DOI":"10.1073\/pnas.1005005107","article-title":"alphabetagamma-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction","volume":"107","author":"Greten-Harrison","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920308785915218","article-title":"Alpha-synuclein misfolding and neurodegenerative diseases","volume":"9","author":"Uversky","year":"2008","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0169-328X(01)00257-1","article-title":"Protein\u2013protein interactions of alpha-synuclein in brain homogenates and transfected cells","volume":"95","author":"Payton","year":"2001","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0145","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0150","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0155","series-title":"Recent Research Developments in Proteins","first-page":"153","article-title":"Biophysical properties of human alpha-synuclein and its role in Parkinson's disease","author":"Uversky","year":"2002"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0959-440X(94)90064-7","article-title":"Small angle X-ray scattering studies of protein folding","volume":"4","author":"Lattman","year":"1994","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0165","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1016\/S1359-0278(96)00047-8","article-title":"X-ray solution scattering studies of protein folding","volume":"1","author":"Kataoka","year":"1996","journal-title":"Fold. Des."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0170","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1006\/jmbi.1996.0535","article-title":"Protein globularization during folding. A study by synchrotron small-angle X-ray scattering","volume":"262","author":"Semisotnov","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0175","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pro.5560060219","article-title":"Structural characterization of the molten globule of alpha-lactalbumin by solution X-ray scattering","volume":"6","author":"Kataoka","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1006\/jmbi.1998.1741","article-title":"Anion-induced folding of Staphylococcal nuclease: characterization of multiple equilibrium partially folded intermediates","volume":"278","author":"Uversky","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1359-0278(98)00027-3","article-title":"Chain-like conformation of heat-denatured ribonuclease A and cytochrome c as evidenced by solution X-ray scattering","volume":"3","author":"Hagihara","year":"1998","journal-title":"Fold. Des."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0190","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1021\/bi990752+","article-title":"Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH","volume":"38","author":"Uversky","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0195","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/cr990071k","article-title":"Changes in biomolecular conformation seen by small angle X-ray scattering","volume":"101","author":"Doniach","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbapap.2011.03.010","article-title":"Intrinsically disordered proteins may escape unwanted interactions via functional misfolding","volume":"1814","author":"Uversky","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0205","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/pro.630","article-title":"Structures of segments of \u03b1-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formation","volume":"20","author":"Zhao","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0215","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1021\/ja067482k","article-title":"Amino acid bulkiness defines the local conformations and dynamics of natively unfolded alpha-synuclein and tau","volume":"129","author":"Cho","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0220","doi-asserted-by":"crossref","first-page":"18314","DOI":"10.1021\/ja904716h","article-title":"Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements","volume":"131","author":"Allison","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0225","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/ja101645g","article-title":"NMR characterization of long-range order in intrinsically disordered proteins","volume":"132","author":"Salmon","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0230","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0235","doi-asserted-by":"crossref","first-page":"30649","DOI":"10.1074\/jbc.C500288200","article-title":"Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation","volume":"280","author":"Bertoncini","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0240","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1021\/ja100646t","article-title":"A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins","volume":"132","author":"Rao","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0245","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1021\/jp068604y","article-title":"Alpha-synuclein tertiary contact dynamics","volume":"111","author":"Lee","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm1589","article-title":"Intrinsically unstructured proteins and their functions","volume":"6","author":"Dyson","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0255","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biocel.2011.04.001","article-title":"Intrinsically disordered proteins from A to Z","volume":"43","author":"Uversky","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0260","doi-asserted-by":"crossref","first-page":"45996","DOI":"10.1074\/jbc.M106777200","article-title":"Residual structure and dynamics in Parkinson's disease-associated mutants of alpha-synuclein","volume":"276","author":"Bussell","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/ja044834j","article-title":"Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations","volume":"127","author":"Dedmon","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0270","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/sj.emboj.7600211","article-title":"NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation","volume":"23","author":"Fernandez","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0275","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbadis.2009.12.004","article-title":"Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions","volume":"1802","author":"Zhou","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0280","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human alpha-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0285","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jmb.2010.07.001","article-title":"Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody","volume":"402","author":"De Genst","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1096\/fj.09-133082","article-title":"Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication","volume":"24","author":"Xie","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1093-3263(00)00138-8","article-title":"Intrinsically disordered protein","volume":"19","author":"Dunker","year":"2001","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.sbi.2006.03.007","article-title":"Recent atomic models of amyloid fibril structure","volume":"16","author":"Nelson","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0305","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nsb838","article-title":"Arrangement of subunits and ordering of beta-strands in an amyloid sheet","volume":"9","author":"Serag","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0310","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsb935","article-title":"Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS","volume":"10","author":"Elam","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0315","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.1073\/pnas.0403756101","article-title":"An amyloid-forming segment of beta 2-microglobulin suggests a molecular model for the fibril","volume":"101","author":"Ivanova","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0320","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine of amyloid-like fibrils","volume":"435","author":"Nelson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0325","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/jmbi.1999.3184","article-title":"A 2.6A structure of a serpin polymer and implications for conformational disease","volume":"293","author":"Huntington","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0330","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"97","author":"Serpell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0335","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-beta spines reveal varied steric zippers","volume":"447","author":"Sawaya","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0340","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1073\/pnas.0712179105","article-title":"The fold of alpha-synuclein fibrils","volume":"105","author":"Vilar","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0345","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1073\/pnas.0506109102","article-title":"Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR","volume":"102","author":"Heise","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0350","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138920311795860160","article-title":"Structures behind the amyloid aggregation of alpha-synuclein: an NMR based approach","volume":"12","author":"Orcellet","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0360","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/bi001315u","article-title":"Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein","volume":"39","author":"Rochet","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0365","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"alpha-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0370","doi-asserted-by":"crossref","first-page":"e4177","DOI":"10.1371\/journal.pone.0004177","article-title":"Granular assembly of alpha-synuclein leading to the accelerated amyloid fibril formation with shear stress","volume":"4","author":"Bhak","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0375","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1021\/bi900872p","article-title":"19F NMR studies of alpha-synuclein conformation and fibrillation","volume":"48","author":"Li","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0380","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1371\/journal.pbio.0020321","article-title":"Mechanism of prion propagation: amyloid growth occurs by monomer addition","volume":"2","author":"Collins","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0385","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/bi992933h","article-title":"Alzheimer's disease amyloid propagation by a template-dependent dock\u2013lock mechanism","volume":"39","author":"Esler","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0390","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1073\/pnas.96.7.3590","article-title":"Designing conditions for in vitro formation of amyloid protofilaments and fibrils","volume":"96","author":"Chiti","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0395","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1073\/pnas.1013225108","article-title":"Low-resolution structure of a vesicle disrupting &alpha;-synuclein oligomer that accumulates during fibrillation","volume":"108","author":"Giehm","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0400","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/092986611794578332","article-title":"Characterization of the non-fibrillar alpha-synuclein oligomers","volume":"18","author":"Hong","year":"2011","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0405","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jmb.2005.10.071","article-title":"Secondary structure of alpha-synuclein oligomers: characterization by Raman and atomic force microscopy","volume":"355","author":"Apetri","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0410","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0415","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0420","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1074\/jbc.M808591200","article-title":"Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer","volume":"284","author":"Kayed","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0425","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0430","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0435","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0440","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0445","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0450","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2010.11.001","article-title":"Prion hypothesis: the end of the controversy?","volume":"36","author":"Soto","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2011.05.008","article-title":"Protein aggregate spreading in neurodegenerative diseases: problems and perspectives","author":"Lee","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molbrainres.2004.09.001","article-title":"Pathogenic effects of alpha-synuclein aggregation","volume":"134","author":"Lundvig","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0465","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/iub.316","article-title":"Oligomeric alpha-synuclein and its role in neuronal death","volume":"62","author":"Brown","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0470","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","article-title":"alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease","volume":"26","author":"Auluck","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0475","doi-asserted-by":"crossref","first-page":"e14292","DOI":"10.1371\/journal.pone.0014292","article-title":"Membrane permeabilization by oligomeric alpha-synuclein: in search of the mechanism","volume":"5","author":"van Rooijen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0480","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/138920310791330659","article-title":"Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease","volume":"11","author":"van Rooijen","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0485","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0490","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2004.10.010","article-title":"The role of alpha-synuclein in neurodegenerative diseases","volume":"105","author":"Bennett","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0500","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-813X(02)00066-9","article-title":"Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T","volume":"23","author":"Li","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0505","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0510","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0515","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0520","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.96.7.3342","article-title":"Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease","volume":"96","author":"Lansbury","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0525","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0530","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Neurodegenerative disease: amyloid pores from pathogenic mutations","volume":"418","author":"Lashuel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0535","doi-asserted-by":"crossref","unstructured":"M.R. Cookson, The biochemistry of Parkinson's disease, Annu Rev Biochem, 74 (2005) 29\u201352.","DOI":"10.1146\/annurev.biochem.74.082803.133400"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0540","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1038\/35041081","article-title":"Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?","volume":"2","author":"Goldberg","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0545","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0550","doi-asserted-by":"crossref","first-page":"48984","DOI":"10.1074\/jbc.M208194200","article-title":"Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion","volume":"277","author":"Gosavi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0555","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0560","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0565","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.1067389","article-title":"Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease","volume":"295","author":"Auluck","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0570","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","article-title":"Pharmacological prevention of Parkinson disease in Drosophila","volume":"8","author":"Auluck","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0575","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0580","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1097\/01.CCM.0000191712.96336.51","article-title":"Posttranslational protein modifications","volume":"33","author":"Clark","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0585","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/cr990076h","article-title":"Mass spectrometry in proteomics","volume":"101","author":"Aebersold","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0590","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"Beyer","year":"2006","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0595","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0600","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0605","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0610","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00401-003-0811-1","article-title":"Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy","volume":"107","author":"Nishie","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0615","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0620","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1523\/JNEUROSCI.0482-05.2005","article-title":"Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0625","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease","volume":"18","author":"Azeredo da Silveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0630","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","article-title":"Enhanced phosphatase activity attenuates {alpha}-synucleinopathy in a mouse model","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0635","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein\u2013membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0640","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0014-5793(02)02861-2","article-title":"Activation of Pyk2\/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases","volume":"521","author":"Nakamura","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0645","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0650","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0006-291X(03)00814-3","article-title":"Biological selectivity and functional aspects of protein tyrosine nitration","volume":"305","author":"Ischiropoulos","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0655","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0660","doi-asserted-by":"crossref","first-page":"27230","DOI":"10.1074\/jbc.M212436200","article-title":"Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications","volume":"278","author":"Norris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0665","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0670","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(03)00367-3","article-title":"Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers","volume":"542","author":"Yamin","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0675","doi-asserted-by":"crossref","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0680","doi-asserted-by":"crossref","first-page":"7823","DOI":"10.1021\/ac901176t","article-title":"Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease","volume":"81","author":"Danielson","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0685","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1021\/ja2009554","article-title":"Allostery in a disordered protein: oxidative modifications to alpha-synuclein act distally to regulate membrane binding","volume":"133","author":"Sevcsik","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0690","doi-asserted-by":"crossref","first-page":"e9956","DOI":"10.1371\/journal.pone.0009956","article-title":"Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0695","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M000206200","article-title":"Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies","volume":"275","author":"Souza","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0700","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0705","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbapap.2004.10.008","article-title":"Methionine oxidation, alpha-synuclein and Parkinson's disease","volume":"1703","author":"Glaser","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0710","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1021\/bi049979h","article-title":"Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein","volume":"43","author":"Hokenson","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0715","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-5793(02)02638-8","article-title":"Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro","volume":"517","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0720","doi-asserted-by":"crossref","first-page":"27630","DOI":"10.1074\/jbc.M303302200","article-title":"Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein","volume":"278","author":"Yamin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0725","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbapap.2004.08.007","article-title":"The oxidative environment and protein damage","volume":"1703","author":"Davies","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0730","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00249-010-0595-x","article-title":"The structure of dopamine induced alpha-synuclein oligomers","volume":"39","author":"Rekas","year":"2010","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0735","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11064-009-9986-8","article-title":"Modulation of alpha-synuclein aggregation by dopamine: a review","volume":"34","author":"Leong","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0740","doi-asserted-by":"crossref","first-page":"e3394","DOI":"10.1371\/journal.pone.0003394","article-title":"Inhibition of alpha-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region","volume":"3","author":"Herrera","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0745","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2010.03.044","article-title":"Dopamine quinones interact with alpha-synuclein to form unstructured adducts","volume":"394","author":"Bisaglia","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0750","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3858\/emm.2011.43.4.026","article-title":"Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers","volume":"43","author":"Lee","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0755","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/bi0485528","article-title":"Ubiquitination of alpha-synuclein","volume":"44","author":"Nonaka","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0760","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)63633-4","article-title":"Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies","volume":"163","author":"Sampathu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0765","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0770","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-005-1066-9","article-title":"Progressive accumulation of ubiquitin and disappearance of alpha-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas\u2013Braak method","volume":"110","author":"Sakamoto","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0775","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/anie.201005546","article-title":"Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated alpha-synuclein","volume":"50","author":"Hejjaoui","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0780","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","article-title":"Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells","volume":"283","author":"Rott","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0785","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2202-5-14","article-title":"Parkin counteracts symptoms in a Drosophila model of Parkinson's disease","volume":"5","author":"Haywood","year":"2004","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0790","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0896-6273(03)00143-0","article-title":"Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila","volume":"37","author":"Yang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0795","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-4159.2009.06124.x","article-title":"The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease","volume":"110","author":"Lee","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0800","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1074\/jbc.M510127200","article-title":"Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein","volume":"281","author":"Dorval","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2011.01.039","article-title":"Human Polycomb protein 2 promotes alpha-synuclein aggregate formation through covalent SUMOylation","volume":"1381","author":"Oh","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60961-8","article-title":"Advanced glycosylation: chemistry, biology, and implications for diabetes and aging","volume":"23","author":"Bucala","year":"1992","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0815","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","article-title":"Crosslinking of alpha-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in Lewy body formation?","volume":"20","author":"Munch","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0820","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jnr.21644","article-title":"Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation","volume":"86","author":"Shaikh","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0825","doi-asserted-by":"crossref","first-page":"e9052","DOI":"10.1371\/journal.pone.0009052","article-title":"Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2011-101965","article-title":"Role of advanced glycation on aggregation and DNA binding properties of alpha-synuclein","volume":"24","author":"Padmaraju","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0835","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0840","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbrc.2008.12.005","article-title":"The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers","volume":"378","author":"Nasstrom","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0845","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.freeradbiomed.2010.11.027","article-title":"The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties","volume":"50","author":"Nasstrom","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0850","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M608126200","article-title":"Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation","volume":"282","author":"Qin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0855","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bi061853s","article-title":"The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation","volume":"46","author":"Siegel","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0860","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1074\/jbc.M608589200","article-title":"Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins","volume":"282","author":"Murray","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0865","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1021\/ar0500766","article-title":"Small molecule oxidation products trigger disease-associated protein misfolding","volume":"39","author":"Bieschke","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0870","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1471-4159.1993.tb03636.x","article-title":"Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau","volume":"61","author":"Dudek","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0875","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1096\/fj.03-0829fje","article-title":"Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease","volume":"18","author":"Andringa","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0880","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1073\/pnas.0438021100","article-title":"Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies","volume":"100","author":"Junn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0885","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1074\/jbc.M809067200","article-title":"Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease","volume":"284","author":"Schmid","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0890","doi-asserted-by":"crossref","first-page":"27252","DOI":"10.1074\/jbc.M109.033969","article-title":"Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies","volume":"284","author":"Nemes","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0895","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1110\/ps.036103.108","article-title":"Tissue transglutaminase modulates alpha-synuclein oligomerization","volume":"17","author":"Segers-Nolten","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0900","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0905","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/glycob\/cwj014","article-title":"Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation","volume":"15","author":"Liu","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0910","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0915","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1021\/bi027363r","article-title":"Role of alpha-synuclein carboxy-terminus on fibril formation in vitro","volume":"42","author":"Murray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0920","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jmb.2008.03.017","article-title":"Characterization of conformational and dynamic properties of natively unfolded human and mouse alpha-synuclein ensembles by NMR: implication for aggregation","volume":"378","author":"Wu","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0925","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0930","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1460-9568.2010.07284.x","article-title":"Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology","volume":"32","author":"Ulusoy","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0935","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.0285-07.2007","article-title":"Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo","volume":"27","author":"Periquet","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0940","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1\u2013120): implications for Lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0945","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0968-0004(89)90063-7","article-title":"Protein translocation and turnover in eukaryotic cells","volume":"14","author":"Bradshaw","year":"1989","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0950","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.bbamcr.2008.06.010","article-title":"Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson","volume":"1783","author":"Zabrocki","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0955","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3","article-title":"Sequence complexity of disordered protein","volume":"42","author":"Romero","year":"2001","journal-title":"Proteins"},{"issue":"Suppl. 7","key":"10.1016\/j.bbadis.2011.10.002_bb0960","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/prot.20735","article-title":"Exploiting heterogeneous sequence properties improves prediction of protein disorder","volume":"61","author":"Obradovic","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0965","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/bioinformatics\/bti534","article-title":"RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins","volume":"21","author":"Yang","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0970","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1093\/bioinformatics\/bti541","article-title":"IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content","volume":"21","author":"Dosztanyi","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0975","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0022-2836(91)90499-V","article-title":"Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli","volume":"222","author":"Zimmerman","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0980","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0092-8674(82)90231-8","article-title":"How crowded is the cytoplasm?","volume":"30","author":"Fulton","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0985","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.7112124","article-title":"Living with water stress: evolution of osmolyte systems","volume":"217","author":"Yancey","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb0990","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0968-0004(01)01938-7","article-title":"Macromolecular crowding: obvious but underappreciated","volume":"26","author":"Ellis","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb0995","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.1074\/jbc.R100005200","article-title":"The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media","volume":"276","author":"Minton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1000","doi-asserted-by":"crossref","first-page":"27383","DOI":"10.1074\/jbc.M802393200","article-title":"Macromolecular crowding compacts unfolded apoflavodoxin and causes severe aggregation of the off-pathway intermediate during apoflavodoxin folding","volume":"283","author":"Engel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1005","doi-asserted-by":"crossref","first-page":"17586","DOI":"10.1073\/pnas.1006760107","article-title":"Structure, function, and folding of phosphoglycerate kinase are strongly perturbed by macromolecular crowding","volume":"107","author":"Dhar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0959-440X(99)00045-7","article-title":"Implications of macromolecular crowding for protein assembly","volume":"10","author":"Minton","year":"2000","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1015","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1110\/ps.24301","article-title":"Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c","volume":"10","author":"Morar","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/jp809817s","article-title":"Effect of dehydration on the aggregation kinetics of two amyloid peptides","volume":"113","author":"Mukherjee","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1025","doi-asserted-by":"crossref","first-page":"30148","DOI":"10.1074\/jbc.M109.002832","article-title":"Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding","volume":"284","author":"Zhou","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bpj.2009.05.026","article-title":"Common crowding agents have only a small effect on protein\u2013protein interactions","volume":"97","author":"Phillip","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nbt1066","article-title":"Evolutionary optimization of fluorescent proteins for intracellular FRET","volume":"23","author":"Nguyen","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1040","doi-asserted-by":"crossref","first-page":"e15608","DOI":"10.1371\/journal.pone.0015608","article-title":"Crowding alone cannot account for cosolute effect on amyloid aggregation","volume":"6","author":"Sukenik","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(02)02446-8","article-title":"Accelerated alpha-synuclein fibrillation in crowded milieu","volume":"515","author":"Uversky","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1050","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1021\/bi0120906","article-title":"Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?","volume":"41","author":"Shtilerman","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/092986608786071102","article-title":"Concerted action of metals and macromolecular crowding on the fibrillation of alpha-synuclein","volume":"15","author":"Munishkina","year":"2008","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmr.699","article-title":"The effect of macromolecular crowding on protein aggregation and amyloid fibril formation","volume":"17","author":"Munishkina","year":"2004","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1065","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1021\/bi8008399","article-title":"Guiding protein aggregation with macromolecular crowding","volume":"47","author":"Munishkina","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/156720509788486491","article-title":"Accelerated fibrillation of alpha-synuclein induced by the combined action of macromolecular crowding and factors inducing partial folding","volume":"6","author":"Munishkina","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1075","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1021\/bi034938r","article-title":"Role of protein\u2013water interactions and electrostatics in alpha-synuclein fibril formation","volume":"43","author":"Munishkina","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1212\/WNL.39.5.660","article-title":"Environmental factors and Parkinson's disease: a case\u2013control study in China","volume":"39","author":"Tanner","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0166-2236(89)90135-5","article-title":"The role of environmental toxins in the etiology of Parkinson's disease","volume":"12","author":"Tanner","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-813X(02)00099-2","article-title":"Environmental factors in Parkinson's disease","volume":"23","author":"Di Monte","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1566-2772(01)00020-2","article-title":"The role of environmental agents in Parkinson's disease","volume":"1","author":"Di Monte","year":"2001","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00441-004-0937-z","article-title":"Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration","volume":"318","author":"Uversky","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1115","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson's disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1120","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1248\/bpb.34.92","article-title":"Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL\/6 mice","volume":"34","author":"Inden","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0161-813X(02)00067-0","article-title":"Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease","volume":"23","author":"Uversky","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","article-title":"Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease","volume":"500","author":"Uversky","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000026225","article-title":"Occupational metal exposures and the risk of Parkinson's disease","volume":"18","author":"Gorell","year":"1999","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1150","first-page":"239","article-title":"Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease","volume":"20","author":"Gorell","year":"1999","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1054\/mehy.1997.0701","article-title":"Aluminum-containing antacids as a cause of idiopathic Parkinson's disease","volume":"53","author":"Altschuler","year":"1999","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S0317167100030584","article-title":"Environmental factors in the etiology of Parkinson's disease","volume":"17","author":"Zayed","year":"1990","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1165","first-page":"159","article-title":"Parkinson disease and environmental factors","volume":"38","author":"Zayed","year":"1990","journal-title":"Rev. Epidemiol. Sante. Publique"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mds.870080116","article-title":"Parkinson's disease mortality and the industrial use of heavy metals in Michigan","volume":"8","author":"Rybicki","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.48.3.650","article-title":"Occupational exposures to metals as risk factors for Parkinson's disease","volume":"48","author":"Gorell","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","article-title":"Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis","volume":"56","author":"Hirsch","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","article-title":"Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains","volume":"52","author":"Riederer","year":"1989","journal-title":"J. Neurochem."},{"issue":"Pt 4","key":"10.1016\/j.bbadis.2011.10.002_bb1190","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1195","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease","volume":"52","author":"Dexter","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1200","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.aquatox.2009.02.011","article-title":"The association of metal ion exposure with alpha-synuclein-like immunoreactivity in the central nervous system of fish, Catostomus commersoni","volume":"92","author":"Boudreau","year":"2009","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(94)90833-8","article-title":"Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study","volume":"660","author":"Oestreicher","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(95)00210-S","article-title":"The role of transition metals in the pathogenesis of Parkinson's disease","volume":"134","author":"Kienzl","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0300-483X(94)02962-T","article-title":"Heavy metals and the etiology of Parkinson's disease and other movement disorders","volume":"97","author":"Montgomery","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/b926659c","article-title":"Metalloproteomics and metal toxicology of alpha-synuclein","volume":"2","author":"Santner","year":"2010","journal-title":"Metallomics"},{"issue":"Pt 3","key":"10.1016\/j.bbadis.2011.10.002_bb1230","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1042\/0264-6021:3400821","article-title":"Copper(II)-induced self-oligomerization of alpha-synuclein","volume":"340","author":"Paik","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1235","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1240","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/bi00429a004","article-title":"Conformational states of beta-lactamase: molten-globule states at acidic and alkaline pH with high salt","volume":"28","author":"Goto","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1245","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1021\/bi00466a009","article-title":"Mechanism of acid-induced folding of proteins","volume":"29","author":"Goto","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.87.2.573","article-title":"Acid-induced folding of proteins","volume":"87","author":"Goto","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1255","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1021\/bi00207a018","article-title":"Classification of acid denaturation of proteins: intermediates and unfolded states","volume":"33","author":"Fink","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/abbi.1997.0207","article-title":"Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid","volume":"344","author":"Paik","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1265","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jasms.2008.07.006","article-title":"Protein\u2013metal interactions of calmodulin and alpha-synuclein monitored by selective noncovalent adduct protein probing mass spectrometry","volume":"19","author":"Ly","year":"2008","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1270","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jinorgbio.2005.06.018","article-title":"Metals accelerate the formation and direct the structure of amyloid fibrils of NAC","volume":"99","author":"Khan","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1275","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1074\/jbc.M709634200","article-title":"Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers","volume":"283","author":"Kostka","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1280","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1471-4159.2009.06411.x","article-title":"alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells","volume":"111","author":"Hettiarachchi","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1285","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1290","doi-asserted-by":"crossref","first-page":"22680","DOI":"10.1074\/jbc.M101181200","article-title":"Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization","volume":"276","author":"Nielsen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1295","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1110\/ps.04879704","article-title":"Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain","volume":"13","author":"Lowe","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.mcn.2010.12.004","article-title":"Raised calcium promotes alpha-synuclein aggregate formation","volume":"46","author":"Nath","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1305","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1471-4159.2004.02533.x","article-title":"Annular alpha-synuclein species from purified multiple system atrophy inclusions","volume":"90","author":"Pountney","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF03033776","article-title":"Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy","volume":"7","author":"Pountney","year":"2005","journal-title":"Hypothesis, Neurotox. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1315","doi-asserted-by":"crossref","first-page":"10947","DOI":"10.1021\/bi060939i","article-title":"Calcium-triggered membrane interaction of the alpha-synuclein acidic tail","volume":"45","author":"Tamamizu-Kato","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1320","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson's disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/ja107842f","article-title":"Exploring the structural details of Cu(I) binding to alpha-synuclein by NMR spectroscopy","volume":"133","author":"Binolfi","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1330","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2007.06.052","article-title":"Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study","volume":"424","author":"Bharathi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1335","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/bi101912q","article-title":"Coordination features and affinity of the Cu(2)+ site in the alpha-synuclein protein of Parkinson's disease","volume":"50","author":"Dudzik","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1340","doi-asserted-by":"crossref","first-page":"e15814","DOI":"10.1371\/journal.pone.0015814","article-title":"Alpha-synuclein is a cellular ferrireductase","volume":"6","author":"Davies","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1345","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1021\/ja711415b","article-title":"Copper(II) binding to alpha-synuclein, the Parkinson's protein","volume":"130","author":"Lee","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1350","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1021\/ja800708x","article-title":"Cu2+ binding modes of recombinant alpha-synuclein\u2014insights from EPR spectroscopy","volume":"130","author":"Drew","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1355","doi-asserted-by":"crossref","first-page":"18057","DOI":"10.1021\/ja103338n","article-title":"Structural characterization of a high affinity mononuclear site in the copper(II)\u2013alpha-synuclein complex","volume":"132","author":"Bortolus","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/bi101582p","article-title":"The synucleins are a family of redox-active copper binding proteins","volume":"50","author":"Davies","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1365","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1021\/ic901157w","article-title":"Identification of the minimal copper(II)-binding alpha-synuclein sequence","volume":"48","author":"Jackson","year":"2009","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbapap.2005.11.003","article-title":"NMR mapping of copper binding sites in alpha-synuclein","volume":"1764","author":"Sung","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1375","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pbio.0060006","article-title":"Conformational equilibria in monomeric alpha-synuclein at the single-molecule level","volume":"6","author":"Sandal","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1380","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.01.103","article-title":"Metal binding to alpha-synuclein peptides and its contribution to toxicity","volume":"380","author":"Brown","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1385","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1021\/ja101756m","article-title":"Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation","volume":"132","author":"Lucas","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1390","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.freeradbiomed.2011.02.003","article-title":"Redox activity of alpha-synuclein\u2013Cu is silenced by Zn(7)-metallothionein-3","volume":"50","author":"Meloni","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1395","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/prot.22909","article-title":"Compact conformations of alpha-synuclein induced by alcohols and copper","volume":"79","author":"Natalello","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1400","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1096\/fj.09-130039","article-title":"Unique copper-induced oligomers mediate alpha-synuclein toxicity","volume":"23","author":"Wright","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1405","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0891-5849(02)00801-8","article-title":"Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease","volume":"32","author":"Tabner","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1410","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/107385840200800107","article-title":"Iron and Parkinson's disease","volume":"8","author":"Wolozin","year":"2002","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2009.11.080","article-title":"Converse modulation of toxic alpha-synuclein oligomers in living cells by N\u2032-benzylidene-benzohydrazide derivates and ferric iron","volume":"391","author":"Hillmer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1420","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/toxsci\/kfp132","article-title":"Potential role of alpha-synuclein and metallothionein in lead-induced inclusion body formation","volume":"111","author":"Zuo","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1425","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S0317167100029140","article-title":"Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains","volume":"16","author":"Uitti","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1430","first-page":"593","article-title":"Calcium, magnesium and aluminum concentrations in Parkinson's disease","volume":"13","author":"Yasui","year":"1992","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1435","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2006.05.007","article-title":"Metal changes in CSF and peripheral compartments of parkinsonian patients","volume":"248","author":"Bocca","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1440","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/174313211X12966635733312","article-title":"Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case\u2013control study","volume":"14","author":"Aden","year":"2011","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1445","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2011.03.035","article-title":"Dietary intake of metals and risk of Parkinson's disease: a case\u2013control study in Japan","volume":"306","author":"Miyake","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1450","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-1789.2006.00672.x","article-title":"Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism\u2013dementia complex and amyotrophic lateral sclerosis of Guam","volume":"26","author":"Oyanagi","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1455","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of alpha-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1460","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","article-title":"Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein","volume":"277","author":"Golts","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1465","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/elps.200500169","article-title":"Effect of metals on herbicides\u2013alpha-synuclein association: a possible factor in neurodegenerative disease studied by capillary electrophoresis","volume":"26","author":"Andre","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1470","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2007.12.033","article-title":"Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons","volume":"1197","author":"Hashimoto","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1475","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1152\/physrev.1958.38.3.503","article-title":"Manganese in health and disease","volume":"38","author":"Cotzias","year":"1958","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1480","first-page":"13","article-title":"Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias)","volume":"5","author":"Barbeau","year":"1984","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1485","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0892-0362(88)90011-6","article-title":"Parkinsonism: a clinical marker of exposure to neurotoxins","volume":"10","author":"Bleecker","year":"1988","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","article-title":"From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure","volume":"11","author":"Lucchini","year":"2009","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1495","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2011.02.017","article-title":"Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice","volume":"180","author":"Peneder","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1500","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ng.300","article-title":"Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity","volume":"41","author":"Gitler","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1505","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2003.09.064","article-title":"alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter","volume":"354","author":"Pifl","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1510","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/15376516.2011.560210","article-title":"alpha-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-kappaB-mediated pathway","volume":"21","author":"Prabhakaran","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1515","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1520","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1110\/ps.9.12.2489","article-title":"Structural changes in alpha-synuclein affect its chaperone-like activity in vitro","volume":"9","author":"Kim","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1525","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1021\/ja0618649","article-title":"Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement","volume":"128","author":"Binolfi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1530","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1021\/ja803494v","article-title":"Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation","volume":"130","author":"Binolfi","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1535","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1074\/jbc.M410409200","article-title":"p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies","volume":"280","author":"Lindersson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1540","first-page":"2735","article-title":"alpha-Synuclein filaments bind the transcriptional regulator HMGB-1","volume":"15","author":"Lindersson","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1545","series-title":"Molecular Mechanisms of Parkinson's Disease","article-title":"Alpha-synuclein binding proteins","author":"Lindersson","year":"2004"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1471-4159.2010.06599.x","article-title":"Regulation of dopamine transporter function by protein\u2013protein interactions: new discoveries and methodological challenges","volume":"113","author":"Eriksen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1555","article-title":"Identification of novel proteins interacting with both a-synuclein and DJ-1","author":"Jin","year":"2006","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1560","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1021\/bi972776r","article-title":"Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins","volume":"37","author":"Jenco","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1565","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(02)01012-7","article-title":"The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility","volume":"111","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1570","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1575","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/8820","article-title":"Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions","volume":"22","author":"Engelender","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1580","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1471-4159.2001.00301.x","article-title":"Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations","volume":"77","author":"Kawamata","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1585","doi-asserted-by":"crossref","first-page":"23927","DOI":"10.1074\/jbc.M201115200","article-title":"Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein","volume":"277","author":"Ribeiro","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1590","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1595","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1074\/jbc.M507026200","article-title":"Prolyl-isomerase Pin1 accumulates in Lewy bodies of Parkinson disease and facilitates formation of alpha-synuclein inclusions","volume":"281","author":"Ryo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1600","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jmb.2004.05.054","article-title":"Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity","volume":"340","author":"Rekas","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1605","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbrainres.2005.05.022","article-title":"Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death","volume":"139","author":"Kaul","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1610","doi-asserted-by":"crossref","first-page":"27441","DOI":"10.1074\/jbc.M101318200","article-title":"Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein","volume":"276","author":"Sung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1615","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1471-4159.2001.t01-1-00232.x","article-title":"alpha-Synuclein forms a complex with transcription factor Elk-1","volume":"77","author":"Iwata","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1620","doi-asserted-by":"crossref","first-page":"45320","DOI":"10.1074\/jbc.M103736200","article-title":"alpha-Synuclein affects the MAPK pathway and accelerates cell death","volume":"276","author":"Iwata","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1625","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1073\/pnas.92.20.9141","article-title":"NACP, the precursor protein of the non-amyloid beta\/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation","volume":"92","author":"Yoshimoto","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 2","key":"10.1016\/j.bbadis.2011.10.002_bb1630","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3230539","article-title":"Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein\/NAC precursor that bind Abeta and NAC","volume":"323","author":"Jensen","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-8993(01)02575-6","article-title":"Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25\u201335, copper, and eosin","volume":"908","author":"Kim","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1640","doi-asserted-by":"crossref","first-page":"21500","DOI":"10.1074\/jbc.M000099200","article-title":"Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments","volume":"275","author":"Jensen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1645","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1074\/jbc.M102981200","article-title":"Tubulin seeds alpha-synuclein fibril formation","volume":"277","author":"Alim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1650","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","article-title":"alpha-Synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356","volume":"274","author":"Jensen","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"Pt 21","key":"10.1016\/j.bbadis.2011.10.002_bb1655","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1242\/jcs.111.21.3167","article-title":"Tau interacts with src-family non-receptor tyrosine kinases","volume":"111","author":"Lee","year":"1998","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1660","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1046\/j.1471-4159.2000.0752221.x","article-title":"Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex","volume":"75","author":"Ghee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1665","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric alpha-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1670","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1074\/jbc.M110414200","article-title":"alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells","volume":"277","author":"Ahn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1675","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1680","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0896-6273(01)00267-7","article-title":"Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1","volume":"30","author":"Torres","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1685","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/JMN:18:3:229","article-title":"Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase","volume":"18","author":"Elkon","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1690","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1695","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","article-title":"Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells","volume":"99","author":"Tehranian","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1700","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1471-4159.2005.03145.x","article-title":"DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein","volume":"93","author":"Meulener","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1705","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jmb.2005.12.030","article-title":"The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein","volume":"356","author":"Zhou","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1710","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","article-title":"Nuclear localization of alpha-synuclein and its interaction with histones","volume":"42","author":"Goers","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1715","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1471-4159.2002.01024.x","article-title":"alpha-Synuclein exhibits competitive interaction between calmodulin and synthetic membranes","volume":"82","author":"Lee","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1720","doi-asserted-by":"crossref","first-page":"17379","DOI":"10.1074\/jbc.M209020200","article-title":"Parkinson's disease-associated alpha-synuclein is a calmodulin substrate","volume":"278","author":"Martinez","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1725","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.24.005.2009","article-title":"Microtubule depolymerization potentiates alpha-synuclein oligomerization","volume":"1","author":"Esteves","year":"2010","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1735","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1523\/JNEUROSCI.5924-09.2010","article-title":"Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases","volume":"30","author":"Morales","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1740","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/NEN.0b013e318217d95f","article-title":"Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated alpha-synuclein","volume":"70","author":"Mougenot","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1745","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1523\/JNEUROSCI.0297-11.2011","article-title":"Induction of intracellular tau aggregation is promoted by {alpha}-synuclein seeds and provides novel insights into the hyperphosphorylation of tau","volume":"31","author":"Waxman","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1750","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1021\/bi1010927","article-title":"The conformation and the aggregation kinetics of alpha-synuclein depend on the proline residues in its C-terminal region","volume":"49","author":"Meuvis","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1755","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1096\/fj.05-5126fje","article-title":"The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy","volume":"20","author":"Gerard","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1760","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nsmb.1483","article-title":"A regulatable switch mediates self-association in an immunoglobulin fold","volume":"15","author":"Calabrese","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1765","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jmb.2009.01.013","article-title":"A generic mechanism of beta2-microglobulin amyloid assembly at neutral pH involving a specific proline switch","volume":"386","author":"Eichner","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(99)02232-5","article-title":"Immunohistochemical localization and distribution of torsinA in normal human and rat brain","volume":"853","author":"Shashidharan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1775","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0006-8993(00)02702-5","article-title":"TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease","volume":"877","author":"Shashidharan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1780","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-8993(01)02302-2","article-title":"Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain","volume":"900","author":"Walker","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1785","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","article-title":"TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation","volume":"83","author":"McLean","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1790","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1074\/jbc.M802283200","article-title":"CHIP targets toxic alpha-synuclein oligomers for degradation","volume":"283","author":"Tetzlaff","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1795","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2006.10.085","article-title":"Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation","volume":"351","author":"Outeiro","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1800","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI35781","article-title":"Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease","volume":"118","author":"Lo Bianco","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1805","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03033778","article-title":"Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy","volume":"7","author":"Pountney","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1815","doi-asserted-by":"crossref","first-page":"25497","DOI":"10.1074\/jbc.M400255200","article-title":"Hsp70 reduces alpha-synuclein aggregation and toxicity","volume":"279","author":"Klucken","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1820","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","article-title":"Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity","volume":"25","author":"Danzer","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1825","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1021\/bi801475r","article-title":"Interactions between Hsp70 and the hydrophobic core of alpha-synuclein inhibit fibril assembly","volume":"47","author":"Luk","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1830","doi-asserted-by":"crossref","first-page":"38173","DOI":"10.1074\/jbc.M110.127753","article-title":"Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperones","volume":"285","author":"Hinault","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1835","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M109541200","article-title":"Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins","volume":"277","author":"Uversky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1840","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","article-title":"beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor","volume":"32","author":"Hashimoto","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1845","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1471-4159.2008.05776.x","article-title":"Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein","volume":"108","author":"Israeli","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1850","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1111\/j.1742-4658.2010.07889.x","article-title":"Biochemical and biophysical features of both oligomer\/fibril and cell membrane in amyloid cytotoxicity","volume":"277","author":"Stefani","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1855","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M110.173856","article-title":"Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways","volume":"286","author":"Ladiwala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1860","doi-asserted-by":"crossref","first-page":"e20244","DOI":"10.1371\/journal.pone.0020244","article-title":"Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1865","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","article-title":"Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct","volume":"282","author":"Necula","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1870","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1875","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.201100123","article-title":"Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid beta","author":"Ladiwala","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1880","doi-asserted-by":"crossref","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","article-title":"Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers","volume":"285","author":"Ladiwala","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1885","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1890","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1895","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","article-title":"Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid","volume":"39","author":"Conway","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1900","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1142\/S0192415X01000083","article-title":"Anti-HIV activity of medicinal herbs: usage and potential development","volume":"29","author":"Wu","year":"2001","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1905","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pros.10024","article-title":"Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest","volume":"49","author":"Ikezoe","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1910","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/phrs.2000.0761","article-title":"Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells","volume":"43","author":"Gao","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1915","first-page":"2861","article-title":"Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin","volume":"20","author":"Shieh","year":"2000","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1920","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1925","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cbic.201000604","article-title":"Baicalein inhibits formation of alpha-synuclein oligomers within living cells and prevents Abeta peptide fibrillation and oligomerisation","volume":"12","author":"Lu","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1930","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jmb.2008.08.039","article-title":"Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein","volume":"383","author":"Hong","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1935","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1940","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2202-11-57","article-title":"Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1945","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.2174\/138161208786404191","article-title":"Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders","volume":"14","author":"Ono","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1950","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","article-title":"Curcumin inhibits aggregation of alpha-synuclein","volume":"115","author":"Pandey","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1955","first-page":"650794","article-title":"Effects of various flavonoids on the alpha-synuclein fibrillation process","volume":"2010","author":"Meng","year":"2010","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1960","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jmb.2010.10.027","article-title":"The anti-Parkinsonian drug selegiline delays the nucleation phase of alpha-synuclein aggregation leading to the formation of nontoxic species","volume":"405","author":"Braga","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1965","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of alpha-synuclein filament assembly","volume":"45","author":"Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1970","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases","volume":"103","author":"Bodner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1975","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4161\/cc.5.14.2929","article-title":"New directions for neurodegenerative disease therapy: using chemical compounds to boost the formation of mutant protein inclusions","volume":"5","author":"Bodner","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1980","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbapap.2008.09.026","article-title":"Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?","volume":"1794","author":"Hong","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.10.002_bb1985","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.parkreldis.2009.03.002","article-title":"A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P+A53T transgenic mice","volume":"15","author":"Ono","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1990","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1471-4159.2006.04440.x","article-title":"Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone","volume":"101","author":"Inden","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb1995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2000","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cbpa.2010.06.169","article-title":"Intrinsically disordered proteins are potential drug targets","volume":"14","author":"Metallo","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2005","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1021\/ja900616b","article-title":"Multiple independent binding sites for small-molecule inhibitors on the oncoprotein c-Myc","volume":"131","author":"Hammoudeh","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2010","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc\u2013Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2015","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1535-7163.MCT-07-0005","article-title":"Improved low molecular weight Myc\u2013Max inhibitors","volume":"6","author":"Wang","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2020","doi-asserted-by":"crossref","first-page":"13579","DOI":"10.1021\/bi048776q","article-title":"Recombinant EWS-FLI1 oncoprotein activates transcription","volume":"43","author":"Uren","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.0607007104","article-title":"Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins","volume":"104","author":"Ng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2030","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-09-2261","article-title":"Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma","volume":"16","author":"Erkizan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nm.1983","article-title":"A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma","volume":"15","author":"Erkizan","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/prot.340080202","article-title":"Amphipathic helix motif: classes and properties","volume":"8","author":"Segrest","year":"1990","journal-title":"Proteins"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-2275(20)41536-6","article-title":"The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function","volume":"33","author":"Segrest","year":"1992","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2050","doi-asserted-by":"crossref","first-page":"34393","DOI":"10.1074\/jbc.M004851200","article-title":"Interaction of human alpha-synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis","volume":"275","author":"Perrin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2055","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2060","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","article-title":"Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations","volume":"275","author":"McLean","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2065","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","article-title":"Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2070","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2075","doi-asserted-by":"crossref","first-page":"21450","DOI":"10.1074\/jbc.M111.224055","article-title":"{alpha}-Synuclein populates both elongated and broken helix states on small unilamellar vesicles","volume":"286","author":"Lokappa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2080","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1021\/bi052151q","article-title":"A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers","volume":"45","author":"Madine","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2085","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1074\/jbc.M512292200","article-title":"Binding of alpha-synuclein affects the lipid packing in bilayers of small vesicles","volume":"281","author":"Kamp","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2090","doi-asserted-by":"crossref","first-page":"32486","DOI":"10.1074\/jbc.M110.139576","article-title":"Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins","volume":"285","author":"Varkey","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2095","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1021\/jp1121917","article-title":"alpha-Synuclein-induced tubule formation in lipid bilayers","volume":"115","author":"Pandey","year":"2011","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2100","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1021\/bi052584t","article-title":"Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles","volume":"45","author":"Zhu","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2105","doi-asserted-by":"crossref","first-page":"46674","DOI":"10.1074\/jbc.M308231200","article-title":"Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro","volume":"278","author":"Necula","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2110","doi-asserted-by":"crossref","first-page":"40186","DOI":"10.1074\/jbc.M305326200","article-title":"The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation","volume":"278","author":"Zhu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2115","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1074\/jbc.M210136200","article-title":"Lipid binding inhibits alpha-synuclein fibril formation","volume":"278","author":"Zhu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2120","doi-asserted-by":"crossref","first-page":"41958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2125","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1074\/jbc.M108414200","article-title":"Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein","volume":"277","author":"Cole","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2135","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","article-title":"alpha-Synuclein membrane interactions and lipid specificity","volume":"275","author":"Jo","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2140","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/j.1432-1033.2004.04250.x","article-title":"alpha-Synuclein\u2013synaptosomal membrane interactions: implications for fibrillogenesis","volume":"271","author":"Jo","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2145","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/bi052344d","article-title":"Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR","volume":"45","author":"Ramakrishnan","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/protein\/gzp036","article-title":"A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides","volume":"22","author":"Abedini","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2155","doi-asserted-by":"crossref","first-page":"015005","DOI":"10.1088\/1478-3975\/6\/1\/015005","article-title":"A role for helical intermediates in amyloid formation by natively unfolded polypeptides?","volume":"6","author":"Abedini","year":"2009","journal-title":"Phys. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2160","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1021\/jp1006704","article-title":"Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies","volume":"114","author":"Haque","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2165","first-page":"7","article-title":"The genetics of Parkinson's disease: a reconsideration","volume":"40","author":"Golbe","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2170","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/ana.410440709","article-title":"Genetic risk factors in Parkinson's disease","volume":"44","author":"Wood","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2185","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2190","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1074\/jbc.274.12.7619","article-title":"Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro","volume":"274","author":"Giasson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2195","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2200","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/bi7000246","article-title":"The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states","volume":"46","author":"Fredenburg","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2011.10.002_bb2205","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jmb.2009.03.065","article-title":"E46K Parkinson's-linked mutation enhances C-terminal-to-N-terminal contacts in alpha-synuclein","volume":"388","author":"Rospigliosi","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2210","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jmb.2007.07.008","article-title":"Residual structure, backbone dynamics, and interactions within the synuclein family","volume":"372","author":"Sung","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.10.002_bb2220","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T16:12:19Z","timestamp":1713024739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911002250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":444,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0925443911002250"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.10.002","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}